Krempa David bought ETON
May 22, 2026 · Form 4 insider transaction
Krempa David bought 30,591 shares of Eton Pharmaceuticals, Inc. at $3.58 per share, a transaction worth $109.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
30,591
Price
$3.58
Total value
$109.5K
InsiderKrempa David
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 22, 2026
Filing dateMay 27, 2026
Shares owned after68,046
OwnershipDirect
10b5-1 planNo
AmendedNo